IC
Posted:
June 06, 2026
Location:
Remote, Poland, Poland
Job Description
Clinical Trial Manager II - Bulgaria, Romania, Poland, Spain, Czech Republic, Hungary - Sponsor Dedicated - Global Study Management Experience is required
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
As a **Clinical Trial Manager II** at ICON, you will design and analyze clinical trials, interpreting complex medical data, and contribute to the advancement of innovative treatments and therapies for one of our sponsor´s studies.
**What You Will Do:**
You will oversee clinical trial management workstreams, ensuring deliverables meet quality and timeline expectations.
Key responsibilities include:
+ Collaborate with cross-functional teams to design and implement effective clinical trial enrollment Collaborating with cross-f...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
As a **Clinical Trial Manager II** at ICON, you will design and analyze clinical trials, interpreting complex medical data, and contribute to the advancement of innovative treatments and therapies for one of our sponsor´s studies.
**What You Will Do:**
You will oversee clinical trial management workstreams, ensuring deliverables meet quality and timeline expectations.
Key responsibilities include:
+ Collaborate with cross-functional teams to design and implement effective clinical trial enrollment Collaborating with cross-f...
Apply for this Job
Submit your application for the Clinical Trial Manager II position at ICON Clinical Research.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Remote, Poland
Posted:
June 06, 2026
Deadline:
June 11, 2026